SESSION TITLE: Procedures 2
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: A bronchial genomic classifier was developed and validated to improve the sensitivity and NPV of bronchoscopy for lung cancer detection. The Percepta® classifier identifies patients at low risk of malignancy who may be considered for radiographic monitoring instead of invasive procedure following inconclusive bronchoscopy. This registry is designed to observe physician adoption, evaluate the impact of Percepta on management decisions, and monitor test safety.